Israeli pharma sector gets capacity boost from IAG
Businesses in the Israeli capital are benefitting from a massive increase in capacity on the IAG Cargo London Heathrow service.
May 1, 2014
Businesses in the Israeli capital are benefitting from a massive increase in capacity on the IAG Cargo London Heathrow service. The additional capacity is the result of replacing narrowbody A321 aircraft with widebody B777 aircraft on seven of the 14 weekly flights from London to Tel Aviv and on the return leg. The B777 has been operating on the route since 30 March 2014 and is set up to carry 18 tonnes on the Heathrow-Tel Aviv route and 16 tonnes on the Tel Aviv- Heathrow leg.
The additional capacity has been earmarked by the carrier to help target Tel Aviv’s high-growth pharmaceuticals market. Israel is a major manufacturing hub for pharmaceutical products and is seen as an important centre for the production of biopharma, due to low start-up costs and a large population of angel investors. Its burgeoning life sciences sector grew from 300 companies in 2003 to more than 900 in 2012, according to trade group Israel Advanced Technology Industries.